Actionnariat et activité des initiés pour TG Therapeutics, Inc. (TGTX): transactions des initiés, déclarations de trading du Sénat et de la Chambre américaine et actions en circulation. Suivez comment dirigeants et politiciens négocient le titre.
Prix
| Prix | $55.85 |
| Capitalisation | $8.5B |
| Bourse | NASDAQ |
| Pays | US |
Transactions d'Initiés Récentes
| Date | Initié | Type | Actions | Valeur |
|---|---|---|---|---|
| 2026-09-10 | Charney Laurence N | S-Sale | 5,000 | $275K |
| 2026-08-06 | Charney Laurence N | G-Gift | 5,100 | |
| 2026-08-07 | Charney Laurence N | G-Gift | 500 | |
| 2026-08-07 | Charney Laurence N | G-Gift | 450 | |
| 2026-06-11 | Lonial Sagar | A-Award | 8,325 | |
| 2026-06-11 | HUME DANIEL | A-Award | 8,325 | |
| 2026-06-11 | Hoberman Kenneth | A-Award | 8,325 | |
| 2026-06-11 | Echelard Yann | A-Award | 8,325 | |
| 2026-06-11 | Charney Laurence N | A-Award | 8,325 | |
| 2026-01-28 | Charney Laurence N | G-Gift | 30,000 |
Bilan (10 ans)
| Année | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Trésorerie | $25.0M | $56.7M | $42.0M | $112.6M | $553.4M | $298.9M | $102.3M | $92.9M | $179.9M | $79.1M |
| Placements à Court Terme | $19.9M | $28.0M | $26.8M | $27.8M | $52.0M | $15.9M | $59.4M | $124.6M | $131.1M | $62.8M |
| Créances | $83852 | $108468 | $95000 | 0 | 0 | $1.4M | 0 | $51.1M | $129.2M | $305.6M |
| Stocks | $5.6M | $7.9M | $9.7M | 0 | 0 | 0 | 0 | $39.8M | $110.5M | $125.6M |
| Actifs Courants | $50.9M | $93.3M | $79.0M | $149.2M | $611.7M | $331.0M | $168.3M | $317.9M | $566.4M | $630.8M |
| Immobilisations Corporelles | $2.4M | $2.7M | $2.5M | $11.8M | $11.8M | $11.1M | $10.8M | $8.1M | $7.2M | $6.3M |
| Goodwill | $799391 | $799391 | $799000 | $799000 | $799000 | $799000 | $799000 | $799000 | 0 | 0 |
| Actifs Incorporels | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Totaux | $54.8M | $97.4M | $83.6M | $163.0M | $625.6M | $379.6M | $193.6M | $329.6M | $577.7M | $1.06B |
| Dettes Fournisseurs | $15.3M | $25.9M | $36.4M | 0 | 0 | 0 | 0 | 0 | 0 | $107.5M |
| Dette à Court Terme | $68875 | $127614 | $67000 | 0 | $22.2M | $975000 | 0 | 0 | 0 | $1.0M |
| Passifs Courants | $16.9M | $28.0M | $38.9M | $84.4M | $87.6M | $65.4M | $53.2M | $53.7M | $90.7M | $153.8M |
| Dette à Long Terme | 0 | 0 | 0 | $29.0M | $7.7M | $66.8M | $71.1M | $100.1M | $244.4M | $252.7M |
| Passifs Totaux | $54.8M | $97.4M | $59.6M | $124.4M | $106.3M | $142.5M | $135.0M | $169.1M | $355.3M | $415.2M |
| Réserves | -$236.4M | -$354.9M | -$528.3M | -$701.2M | -$980.6M | -$1.33B | -$1.53B | -$1.55B | -$1.53B | -$1.08B |
| Capitaux Propres | $35.9M | $67.0M | $24.0M | $38.6M | $519.4M | $237.2M | $58.6M | $160.5M | $222.4M | $648.0M |
| Dette Totale | $68875 | $127614 | $67000 | $40.8M | $42.0M | $79.0M | $83.1M | $110.8M | $253.7M | $260.7M |
| Dette Nette | -$44.9M | -$84.7M | -$68.7M | -$99.6M | -$563.5M | -$235.7M | -$78.6M | -$106.7M | -$57.3M | $118.8M |
| Fonds de Roulement | $34.0M | $65.4M | $40.2M | $64.7M | $524.2M | $265.6M | $115.1M | $264.2M | $475.7M | $477.0M |
Santé financière
| Dette / Capitaux propres | 1.25 |
| Ratio de liquidité | 4.27 |
Rentabilité
| Marge brute | 82.36% |
| Marge opérationnelle | 17.05% |
| Marge nette | 55.22% |
Entreprises liées: ACLX · ALKS · ARWR · CRSP · IMVT · KRYS · KYMR
Explorer le secteur: Healthcare · Biotechnology
Plus de sections de TGTX: Vue d'ensemble · Financiers · Valorisation · Statistiques · Estimations · Technique · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions